Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Autolus Therapeutics (AUTL) Gross Profit (2024 - 2025)

Historic Gross Profit for Autolus Therapeutics (AUTL) over the last 2 years, with Q3 2025 value amounting to -$7.4 million.

  • Autolus Therapeutics' Gross Profit changed N/A to -$7.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$31.3 million, marking a year-over-year change of. This contributed to the annual value of -$1.3 million for FY2024, which is 17461.72% down from last year.
  • Autolus Therapeutics' Gross Profit amounted to -$7.4 million in Q3 2025.
  • Autolus Therapeutics' 5-year Gross Profit high stood at $10.1 million for Q1 2024, and its period low was -$11.4 million during Q4 2024.